Diagnostic Performance of 18F-FDG PET/CT in Detecting Distant Metastases in Breast Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University
About this trial
compare the accuracy and sensitivity of 18F FDG-PET/CT and CE-CT in detecting distant metastases in breast cancer
Eligibility criteria
Qualifiers
Patients with pathologically proven breast cancer
Metastatic breast cancer proved by pathology or radiological modalities.
Interval between 18F-FDG PET/CT and CE-CT from one to three weeks.
Disqualifiers
Patients with known concomitant malignancy
Patients receive systemic treatment chemotherapy or radiotherapy between 18F-FDG PET/CT and CE-CT.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
97 Participants
are grouped into 1 trial groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov